BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 28825044)

  • 1. Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.
    Shah F; Logsdon D; Messmann RA; Fehrenbacher JC; Fishel ML; Kelley MR
    NPJ Precis Oncol; 2017; 1():. PubMed ID: 28825044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APE1/Ref-1 as a Novel Target for Retinal Diseases.
    Heisel C; Yousif J; Mijiti M; Charizanis K; Brigell M; Corson TW; Kelley MR
    J Cell Signal; 2021; 2(2):133-138. PubMed ID: 34322687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells.
    McIlwain DW; Fishel ML; Boos A; Kelley MR; Jerde TJ
    Oncotarget; 2018 Feb; 9(13):10962-10977. PubMed ID: 29541389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.
    Sahakian L; Filippone RT; Stavely R; Robinson AM; Yan XS; Abalo R; Eri R; Bornstein JC; Kelley MR; Nurgali K
    Inflamm Bowel Dis; 2021 Feb; 27(3):388-406. PubMed ID: 32618996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
    Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
    PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
    Fishel ML; Kelley MR
    Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
    Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
    J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
    Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.
    Fishel ML; Jiang Y; Rajeshkumar NV; Scandura G; Sinn AL; He Y; Shen C; Jones DR; Pollok KE; Ivan M; Maitra A; Kelley MR
    Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
    Laev SS; Salakhutdinov NF; Lavrik OI
    Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
    Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
    Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
    Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
    Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
    Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
    Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.
    Schindl M; Oberhuber G; Pichlbauer EG; Obermair A; Birner P; Kelley MR
    Int J Oncol; 2001 Oct; 19(4):799-802. PubMed ID: 11562758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes.
    Baek H; Lim CS; Byun HS; Cho HS; Lee YR; Shin YS; Kim HW; Jeon BH; Kim DW; Hong J; Hur GM; Park JB
    Mol Brain; 2016 Dec; 9(1):99. PubMed ID: 27986089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The APE1/REF-1 and the hallmarks of cancer.
    Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
    Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
    Jiang A; Gao H; Kelley MR; Qiao X
    Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.
    Gampala S; Moon HR; Wireman R; Peil J; Kiran S; Mitchell DK; Brewster K; Mang H; Masters A; Bach C; Smith-Kinnamen W; Doud EH; Rai R; Mosley AL; Quinney SK; Clapp DW; Hamdouchi C; Wikel J; Zhang C; Han B; Georgiadis MM; Kelley MR; Fishel ML
    Pharmacol Res; 2024 Mar; 201():107092. PubMed ID: 38311014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.
    Kelley MR; Georgiadis MM; Fishel ML
    Curr Mol Pharmacol; 2012 Jan; 5(1):36-53. PubMed ID: 22122463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen peroxide activates APE1/Ref-1 via NF-κB and Parkin: a role in liver cancer resistance to oxidative stress.
    Siswanto FM; Okukawa K; Tamura A; Oguro A; Imaoka S
    Free Radic Res; 2023 Dec; 57(3):223-238. PubMed ID: 37364176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.